中慧生物：公司H股已获选定并将纳入恒生综合指数成份股 自2026年3月9日起生效
Jin Rong Jie·2026-02-16 00:23
Group 1 - The company Zhonghui Biotech has been selected for inclusion in the Hang Seng Composite Index, effective from March 9, 2026 [1] - The Hang Seng Composite Index serves as a comprehensive indicator for H-shares, covering the top 95% of companies by market capitalization listed on the Hong Kong Stock Exchange [1] - The index is widely utilized by index funds, mutual funds, and performance evaluation systems [1]